29 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
for examination and packaging by the Agent in The City of New York not later than noon (New York time) on the Business Day prior to the Settlement Date.
(e … , packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product
8-K/A
CMMB
Chemomab Therapeutics Ltd
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
, post-approval clinical data, labeling, packaging, distribution, adverse event reporting, storage, recordkeeping, export, import, advertising
424B3
99ichx6yyq y5992p3
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
kzcr7zzv4
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
yqagiwfe1 nh
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.1
abqhxqccchn47f
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.6
uovxxo0oqo09dl
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
10-K
1cco mdya31bii
17 Mar 20
Annual report
5:27pm
8-K
EX-99.1
oqxxr
4 Feb 20
TARGETING GENETICALLY - DEFINED CANCERS Corporate Presentation February 2020
12:00am
6-K
EX-10.1
ck3cyfh
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
20-F/A
pn2su47tog445ag8 bsw
24 Apr 19
Annual report (foreign) (amended)
5:19pm
424B4
si1ijuei iry28r7drl
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
zx07 bv14
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
cpnzlpr09f9ib6yh zp4
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.3
s6dqr9xc9085dnjyb4
5 Feb 19
Registration statement (foreign) (amended)
5:30pm